Therefore, targeting the Pin1-SPOP-Nanog axis and the AMPK-BRAF-Nanog/SPOP-Nanog axis may offer promising therapeutic strategies for PCa in the future. This evidence concerns the gene BRAF and posterior cortical atrophy.